Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer

Go back to Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer
(NASDAQ: RANI) Delayed: 0.88 +0.03 (3.53%)
Previous Close $0.85    52 Week High
Open $0.88    52 Week Low
Day High $0.90    P/E N/A 
Day Low $0.86    EPS
Volume 708,399